News & Events
New Pathway to Treat Heart Failure
Researchers discover a new way to keep the heart pumping, which could lead to new drugs for heart disease.
Patients with Inflammation More Likely to Develop Diabetes after Transplant
A new study in kidney transplant recipients suggests that patients with more inflammation prior to surgery are more likely to develop diabetes than those with less overall inflammation.
Natural Molecule Could Improve Parkinson’s
A natural molecule shows benefit in a preliminary clinical trial for Parkinson’s disease
A Broken Calorie Sensing Pathway: How Overeating May Lead to More Eating
New research shows that overeating reduces levels of a hormone that signals the feeling of fullness in the brain, potentially promoting more eating.
Jefferson Receives $2 Million from Philanthropist and Real Estate Developer Steven H. Korman to Fund New Community Engagement Center
Thomas Jefferson University is proud to announce a $2 million gift from Steven H. Korman to fund the creation of the Steven H. Korman Center for Community Engagement.
Blood-born Molecules Could Predict Those Who Will Develop Liver Cancer
A panel of microRNAs from blood samples may predict patients at high risk of developing a common liver cancer from hepatitis B virus infection.
Thomas Jefferson University and Jefferson Health Recognized By CIO As One Of The CIO 100 Award Winners
IDG's CIO today announces Jefferson as a recipient of the 2016 CIO 100.
Treating Sleep Apnea Could Reduce Emergencies in Hospitalized Patients
Research published in PLOS ONE says that treating high-risk hospitalized patients for sleep apnea may decrease the frequency of emergency rescues from hospital personnel.
Nearly Half of Heart Bypass Patients Skip Medications that Keep Blood Flowing
Researchers at Thomas Jefferson University discovered that nearly half of coronary artery bypass patients are not taking statins and aspirin together when they are referred for diagnostic cardiac catheterization at least three years after their initial bypass